AI-generated summary
The authors studied the effect of red light photobiomodulation at 660 nm on oral squamous cell carcinoma tumors grown in mice from patient-derived samples, comparing irradiated and non-irradiated groups. They report no significant differences in tumor volume, histological grade, or the markers and cell cycle phases they measured, and conclude that the therapy did not change tumor behavior in this model.
- Who or what was studied
- BALB/c nude mice with patient-derived oral squamous cell carcinoma xenograft models, divided into control, immediate irradiation (n = 6), and late irradiation (n = 6) groups, with 8 in the control group.
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in a mouse xenograft model with small group sizes, so findings may not apply directly to cancer patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 6 J/cm2
- Power
- 100 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.